H11.043
Peripheral pterygium, stationary, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Peripheral pterygium is a benign growth that appears on the conjunctiva—the clear tissue covering the white part of the eye. When it develops in the peripheral area of the eye, it is called peripheral pterygium. In cases categorized as stationary, the growth remains stable over time and does not tend to invade or alter the cornea significantly. Bilateral peripheral pterygium affects both eyes, often sharing similar features, and is typically linked to environmental factors such as exposure to sunlight and wind. Recognizing this condition is important for managing eye health and understanding its potential implications.
Causes & Symptoms
Clinical Causes: Prolonged exposure to ultraviolet (UV) light from the sun Environmental irritants such as wind, dust, and smoke Chronic eye irritation and dryness Genetic predisposition and family history Age-related changes that affect eye tissues
Key Symptoms: Growth of a fleshy tissue on the outer edge of the cornea Mild redness or inflammation around the growth Discomfort or a sensation of dryness in the affected eye Possible irritation when exposed to bright light or wind No significant vision loss in early stages, though growth may extend into the cornea over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis of peripheral pterygium involves a comprehensive eye examination performed by an eye care specialist. The ophthalmologist will inspect the eye's surface, identify any abnormal tissue growth, and assess its size, location, and whether it has begun to encroach onto the cornea. In some cases, additional imaging tests or slit-lamp examination may be utilized to get a detailed view. The stationary nature of the pterygium is confirmed through repeated examinations over time, ensuring that the growth has not changed or advanced.
Treatment Protocols: Management options for peripheral pterygium depend on its size, symptoms, and whether it affects vision. When small and asymptomatic, observation and regular monitoring may be sufficient. For growth that causes discomfort or threatens to encroach upon the cornea, treatment options include: - **Surgical removal:** A procedure to excise the abnormal tissue, typically performed in an outpatient setting. - **Protective measures:** Use of sunglasses or UV-protective eyewear to limit further exposure to sunlight and environmental irritants. - **Artificial tears:** Eye drops to alleviate dryness and irritation. - **Postoperative care:** After surgery, eye medications and follow-up visits are essential to prevent recurrence and monitor healing. Preventive strategies involve reducing exposure to risk factors, including wearing protective eyewear and managing environmental irritants.
Clinical Advice & FAQs
Billing Guidance
Is H11.043 a billable ICD-10 code?
Yes, H11.043 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H11.043?
Clinical documentation must specify the nature of Peripheral pterygium, stationary, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
